{
  "figure_1": "Prisma flow diagram",
  "figure_2": "Risk of bias summary: review authors' judgements about each risk of bias item for each included study",
  "figure_3": "Comparison 1: Laser trabeculoplasty versus medication, Outcome 1: Failure to control IOP at 6 months",
  "figure_4": "Comparison 1: Laser trabeculoplasty versus medication, Outcome 2: Failure to control IOP at 12 months",
  "figure_5": "Comparison 1: Laser trabeculoplasty versus medication, Outcome 3: Failure to control IOP at 24 months",
  "figure_6": "Comparison 1: Laser trabeculoplasty versus medication, Outcome 4: Failure to control IOP at 36 months",
  "figure_7": "Comparison 1: Laser trabeculoplasty versus medication, Outcome 5: Failure to control IOP at 5 years",
  "figure_8": "Comparison 1: Laser trabeculoplasty versus medication, Outcome 6: Failure to stabilise visual field progression at 12 months",
  "figure_9": "Comparison 1: Laser trabeculoplasty versus medication, Outcome 7: Failure to stabilise visual field progression at 24 months",
  "figure_10": "Comparison 1: Laser trabeculoplasty versus medication, Outcome 8: Failure to stabilise visual field progression at 48 months",
  "figure_11": "Comparison 1: Laser trabeculoplasty versus medication, Outcome 9: Failure to stabilise optic neuropathy progression at 24 months",
  "figure_12": "Comparison 1: Laser trabeculoplasty versus medication, Outcome 10: Adverse effects: PAS formation",
  "figure_13": "Comparison 1: Laser trabeculoplasty versus medication, Outcome 11: Adverse effects: early IOP spikes",
  "figure_14": "Comparison 2: Laser trabeculoplasty versus trabeculectomy, Outcome 1: Failure to control IOP at 6 months",
  "figure_15": "Comparison 2: Laser trabeculoplasty versus trabeculectomy, Outcome 2: Failure to control IOP at 24 months"
}